Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Planet 13 HoldingsPLNH +5.63%27 Cash-to-Debt is 0.12 as of Jun. 2026, which is 92% below its 10-year median of 1.43. GuruFocus rates PLNH with a GF Score™ of 27/100 and a GF Value™ of $0.25 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 949 Drug Manufacturers companies, Planet 13 Holdings ranks worse than 83.77% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Planet 13 Holdings's cash to debt ratio for the quarter that ended in Jun. 2026 was 0.12.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Planet 13 Holdingscouldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2026.
The historical rank and industry rank for Planet 13 Holdings's Cash-to-Debt or its related term are showing as below:
PLNH'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06 Med: 1.43 Max: 20.86
Current: 0.12
During the past 10 years, Planet 13 Holdings's highest Cash to Debt Ratio was 20.86. The lowest was 0.06. And the median was 1.43.
PLNH's Cash-to-Debt is ranked worse than 83.77% of 949
companies
in the Drug Manufacturers industry
Industry Median: 1
vs PLNH: 0.12
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Planet 13 Holdings Cash-to-Debt Related Terms
Planet 13 Holdings Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Planet 13 Holdings's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, Planet 13 Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Planet 13 Holdings Cash-to-Debt vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Planet 13 Holdings's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Planet 13 Holdings's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Planet 13 Holdings (PLNH) has a Cash-to-Debt of 0.12 as of Jun. 2026. This is 92% below median its historical median of 1.43. Over the past decade, Planet 13 Holdings' Cash-to-Debt has ranged from 0.06 to 20.86. According to the industry distribution chart, Planet 13 Holdings ranks #795 out of 949 companies in the Drug Manufacturers industry, placing it in the top 83.8%.
Is Planet 13 Holdings' Cash-to-Debt too high?
Planet 13 Holdings' current Cash-to-Debt of 0.12 is 92% below median its 10-year median of 1.43. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 20.86. The Drug Manufacturers industry median Cash-to-Debt is 1.00. Planet 13 Holdings' value of 0.12 is 88% below this industry median. Based on the distribution chart, Planet 13 Holdings ranks #795 out of 949 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Planet 13 Holdings has a GF Score™ of 27/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Planet 13 Holdings' Cash-to-Debt compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Planet 13 Holdings ranks #795 out of 949 companies for Cash-to-Debt. This places Planet 13 Holdings in the lower half of its industry. The industry median Cash-to-Debt is 1.00. Planet 13 Holdings' value of 0.12 is 88% below this benchmark. Historically, Planet 13 Holdings' own Cash-to-Debt has ranged from 0.06 to 20.86 over the past decade. While the company's 10-year median is 1.43 vs. the industry median of 1.00, Planet 13 Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Drug Manufacturers company?
The median Cash-to-Debt among Drug Manufacturers companies is 1.00, based on 949 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Planet 13 Holdings's current Cash-to-Debt of 0.12 is 88% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Cash-to-Debt is 1.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Planet 13 Holdings's current Cash-to-Debt is 0.12, which is 92% below median its own 10-year median of 1.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Planet 13 Holdings stock overvalued right now?
Based on GuruFocus' analysis, Planet 13 Holdings (PLNH) is currently considered Possible Value Trap. The stock's GF Value™ is $0.25, compared to a current price of $0.16 — trading 36.2% below its estimated fair value. The current Cash-to-Debt is 0.12, which is 92% below median its 10-year median of 1.43 and 88% below the Drug Manufacturers industry median of 1.00. Planet 13 Holdings' overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Planet 13 Holdings (PLNH), the current Cash-to-Debt is 0.12 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Planet 13 Holdings (PLNH) Overvalued in 2026?
Based on GuruFocus' analysis, Planet 13 Holdings stock appears to be undervalued.
The current stock price of $0.16 is trading 36.2% below its estimated GF Value™ of $0.25.
GuruFocus considers Planet 13 Holdings to be Possible Value Trap.
Key valuation signals for PLNH:
Cash-to-Debt: 0.12 (92% below median its 10-year median of 1.43)
GF Value™: $0.25 vs. price of $0.16 (36.2% below fair value)
Industry Position: 88% below the Drug Manufacturers median (#795 of 949)
No single metric tells the full story. See the PLNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Planet 13 Holdings Inc a vertically integrated cultivator and provider of cannabis and cannabis-infused products in the States of Nevada and California, with retail cannabis operations in Illinois. The company owns and manufactures cannabis products under the following brands: HaHa (gummies and beverages), Dreamland (chocolates), TRENDI (vapes and concentrates), Medizin (flower, vapes, concentrates), Leaf and Vine (vapes).
27GF Score
Get the complete analysis for PLNH
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLNH has been successfully added to your 
